Dobutamine Injection (250mg/20mL)/Hospira: Recall - Visible Particulates
Pradaxa (dabigatran): Drug Safety Communication - Lower Risk for Stroke and Death, but Higher Risk for GI Bleeding Compared to Warfarin
Drug Information Update - FDA reminds health care professionals to stop dispensing prescription combination drug products with more than 325 mg of acetaminophen
Product Warning - Super Arthgold by Nano Well-being Health: Recall - Undeclared Drug Ingredients
Epidural Corticosteroid Injection: Drug Safety Communication - Risk of Rare But Serious Neurologic Problems
Marcaine (Bupivacaine HCI Injection, USP) 0.25 percent, 10 ml, Single-Dose, Preservative-Free Vial: Recall - Visible Particulates
Lidocaine HCI Injection, USP, by Hospira: Recall - Visible Particulates
Acetaminophen Prescription Combination Drug Products with more than 325 mg: FDA Statement - Recommendation to Discontinue Prescribing and Dispensing
Meet Editor-in-Chief Stuart M. Weinstein, MD
Marathon bomb victims adjust to a 'different normal'
AAPM&R Releases List Of Commonly Used Tests And Treatments To Trigger Patient Conversation